The World Health Organization has issued a permit for emergency use Moderna’s Covid-19 vaccine.
The US mRNA vaccine manufacturer introduces the vaccine from Oxford / AstraZeneca, Pfizer / BioNTech and Johnson & Johnson in recognition of the WHO’s emergency program.
Equal recognition of Chinese Sinopharm and the Sinovac vaccine is expected in the coming days and weeks, says WHO.
The Moderna vaccine light, which was announced late on Friday, took months due to delays by the WHO to obtain information from the manufacturer.
Many countries that do not have their own drug testing and evaluation offices rely on the WHO list to decide whether to use the vaccine. The UN children’s agency Unicef is also using a series of emergency vaccines as a pandemic.
The announcement, however, is unlikely to affect the Moderna vaccine in the developing world. The company has partnered with several rich countries, which have already received large sums of money.
In a statement Friday, the company’s chief executive, Stéphane Bancel, said Moderna was “engaged in negotiations with various organizations, such as Covax, to protect people around the world.”
He cites a UN-sponsored program to export Covid-19 vaccines to many low- and middle-income countries, depending on needs.